跳至主要内容
临床试验/NCT06964373
NCT06964373招募中不适用

Cervical Ripening Balloon for Same-Day Cervical Preparation for Second Trimester Termination

University of New Mexico1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2025年4月8日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
70
试验地点
1
主要终点
D&E procedure length (minutes)

研究概览

简要总结

The goal of this clinical trial is to learn if a cervical ripening balloon (Foley balloon) works to prepare the cervix before same-day outpatient dilation and evacuation (D&E). The main questions it aims to answer are:

  • Is cervical preparation with cervical ripening balloon for same-day outpatient D&E non-inferior to cervical preparation with osmotic dilators?
  • How feasible and safe is cervical preparation with cervical ripening balloon for same-day outpatient D&E?
  • How acceptable is cervical preparation with cervical ripening balloon for same-day outpatient D&E?

Participants will:

  • Have cervical preparation with cervical ripening balloon (experimental group) or osmotic dilators (usual care group)
  • Complete two surveys, one about the cervical preparation and one about the D&E procedure

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Individuals who desire outpatient dilation and evacuation (D&E)
  • •At least 18 years of age
  • •Able and willing to consent
  • •Gestational duration between 18 weeks 0 days and 19 weeks 6 days as determined by ultrasound
  • •Able to read and understand English or Spanish
  • •Able to obtain reliable post-procedure transportation
  • •Able to observe fasting guidelines of 6 hours prior to the D&E procedure

排除标准

  • •Medical conditions that require procedural management in the operating room
  • •Preference for D&E procedure in the operating room

研究组 & 干预措施

Osmotic Dilators

Active Comparator

干预措施: Osmotic Dilators (Device)

Cervical Ripening Balloon

Experimental

干预措施: Cervical Ripening Balloon (Device)

结局指标

主要结局

D&E procedure length (minutes)

时间窗: during procedure

From insertion of first instrument to removal of speculum

次要结局

  • Additional sedation medication administered(during procedure)
  • Administration of uterotonic medications(during procedure)
  • Cervical laceration(during procedure)
  • Estimated blood loss > 500 milliliters(From enrollment to 24 hours after enrollment)
  • Hospital transfer(From enrollment to 24 hours after enrollment)
  • Starting dilation (French gauge)(during procedure)
  • Additional dilation (French gauge)(during procedure)
  • Estimated blood loss (milliliters)(during procedure)
  • Pain (Visual Analog Scale)(during procedure)
  • Feasibility of cervical preparation (physician-reported)(From enrollment to 24 hours after enrollment)
  • Likelihood to recommend cervical preparation (participant-reported)(From enrollment to 24 hours after enrollment)
  • Acceptability of cervical preparation (physician-reported)(From enrollment to 24 hours after enrollment)
  • Satisfaction with level of pain management (participant-reported)(From enrollment to 24 hours after enrollment)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验